Dong-yan Shen

Xiamen, 361003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.

Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.

Journal: Heliyon

Published: August 11, 2023

DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation.

DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation.

Journal: International journal of medical sciences

Published: October 21, 2022

Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis.

Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis.

Journal: Mediators of inflammation

Published: July 03, 2022

Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway.

Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway.

Journal: Phytotherapy research : PTR

Published: January 30, 2021

Protective effects of orally administered shark compound peptides from Chiloscyllium plagiosum against acute inflammation.

Protective effects of orally administered shark compound peptides from Chiloscyllium plagiosum against acute inflammation.

Journal: Journal of food biochemistry

Published: September 13, 2020

Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.

Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 09, 2019

Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest And Mitochondria-Mediated Apoptosis.

Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest And Mitochondria-Mediated Apoptosis.

Journal: OncoTargets and therapy

Published: August 06, 2019

The inhibitory kinetics and mechanism of glycolic acid on lipase.

The inhibitory kinetics and mechanism of glycolic acid on lipase.

Journal: Journal of biomolecular structure & dynamics

Published: July 19, 2019

Retinoic acid receptor α facilitates human colorectal cancer progression via Akt and MMP2 signaling.

Retinoic acid receptor α facilitates human colorectal cancer progression via Akt and MMP2 signaling.

Journal: OncoTargets and therapy

Published: January 03, 2019

Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling.

Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling.

Journal: BioMed research international

Published: December 10, 2018

Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.

Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.

Journal: Oncology reports

Published: May 18, 2018

Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.

Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 30, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026